FORA Capital LLC purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 12,869 shares of the financial services provider’s stock, valued at approximately $540,000.
A number of other institutional investors also recently modified their holdings of the company. Renaissance Technologies LLC acquired a new position in Trupanion in the 2nd quarter valued at $4,739,000. Marshall Wace LLP increased its stake in shares of Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after purchasing an additional 116,496 shares during the period. Connors Investor Services Inc. boosted its stake in Trupanion by 31.3% during the 2nd quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock valued at $3,339,000 after purchasing an additional 27,042 shares during the period. Dalton Investments Inc. acquired a new stake in Trupanion in the 2nd quarter valued at approximately $1,029,000. Finally, OmniStar Financial Group Inc. acquired a new position in shares of Trupanion during the third quarter worth approximately $535,000.
Trupanion Stock Down 1.6 %
TRUP stock opened at $53.50 on Friday. The business’s 50 day moving average is $49.73 and its 200-day moving average is $40.06. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on TRUP shares. Stifel Nicolaus upped their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Northland Securities lifted their target price on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Bank of America upped their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Finally, Piper Sandler lifted their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $44.67.
View Our Latest Analysis on TRUP
Insider Buying and Selling at Trupanion
In other news, SVP Emily Dreyer sold 3,100 shares of the stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the sale, the senior vice president now owns 24,708 shares in the company, valued at approximately $1,355,233.80. This represents a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the sale, the chief financial officer now owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,538 shares of company stock worth $988,741 over the last ninety days. Corporate insiders own 5.50% of the company’s stock.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- Which Wall Street Analysts are the Most Accurate?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the Euro STOXX 50 Index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.